Pyronaridine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pyronaridine
Pyronaridine.svg
Systematic (IUPAC) name
4-[(7-chloro-2-methoxy-pyrido[3,2-b]quinolin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol
Clinical data
Legal status
  • CLP (EU): Acute Tox. 3(H301), Eye Dam. 1 (H318), Repr. 2 (H361), Aquatic Chronic 4 (H413)
Routes Oral, intramuscular injection, intravenous therapy
Identifiers
CAS number 74847-35-1 N
ATC code None
PubChem CID 5485198
ChemSpider 10647812 YesY
UNII TD3P7Q3SG6 YesY
ChEMBL CHEMBL35228 YesY
Chemical data
Formula C29H32ClN5O2 
Mol. mass 518.05 g/mol
 N (what is this?)  (verify)

Pyronaridine is an antimalarial drug. It was first synthesized in 1970 and has been in clinical use in China since the 1980s. It was first assayed by Adegoke and Babalola in 2006.[1]

It is one of the components of Pyramax.

References[edit]

  1. ^ Chang C, Lin-Hua T, Jantanavivat C (1992). "Studies on a new antimalarial compound: pyronaridine". Trans R Soc Trop Med Hyg 86 (1): 7–10. doi:10.1016/0035-9203(92)90414-8. PMID 1566313. 

Adegoke & Babalola 2006